A Phase II Trial of Carboplatin Plus Cetuximab for the Treatment of Stage IIIb/IV Non-Small Cell Lung Cancer.

Trial Profile

A Phase II Trial of Carboplatin Plus Cetuximab for the Treatment of Stage IIIb/IV Non-Small Cell Lung Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2010

At a glance

  • Drugs Carboplatin; Cetuximab
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors ImClone Systems
  • Most Recent Events

    • 18 Nov 2008 Checked against ClinicalTrials.gov record.
    • 01 Oct 2008 Actual number of patients enrolled was 50 according to ClinicalTrials.gov record.
    • 16 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top